ACADIA PHARMACEUTICALS INC.: accounts_receivable
| Value | {"amount": 46344000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-09-30) |
| Status | current |
| Entity | ACADIA PHARMACEUTICALS INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:37:10.561182+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fa6d2db4-e8c6-4f49-b439-dc010347ee34
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-20-050566 · Open the official SEC filing →Retrieved: 2026-08-19T10:37:10.561182+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001070494/accounts-receivable/2020-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fa6d2db4-e8c6-4f49-b439-dc010347ee34
History
- no predecessors — first report